Avara Management Ltd
Insider CIK 1814934 · RPRX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2023-12-29 | 2024-01-03 | 65,803 | $28.04 | $1.85M | 2,477,520 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-12-28 | 2023-12-29 | 209,863 | $28.20 | $5.92M | 2,543,323 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-12-27 | 2023-12-29 | 41,729 | $28.01 | $1.17M | 2,753,186 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-12-15 | 2023-12-19 | 10,229 | $28.01 | $286.5K | 2,794,915 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-12-14 | 2023-12-15 | 364,441 | $28.91 | $10.54M | 2,805,144 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2023-12-13 | 2023-12-15 | 307,935 | $28.95 | $8.91M | 3,169,585 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-12-05 | 2022-12-07 | 84,302 | $43.15 | $3.64M | 7,795,072 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-12-02 | 2022-12-05 | 197,766 | $43.98 | $8.70M | 7,879,374 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-12-01 | 2022-12-05 | 165,000 | $44.11 | $7.28M | 22,225,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-28 | 2022-09-30 | 32,593 | $41.05 | $1.34M | 8,077,140 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-22 | 2022-09-26 | 211,380 | $41.17 | $8.70M | 8,109,733 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-21 | 2022-09-22 | 125,697 | $41.25 | $5.19M | 8,321,113 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-20 | 2022-09-22 | 267,815 | $41.02 | $10.99M | 22,390,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-20 | 2022-09-22 | 130,330 | $41.02 | $5.35M | 8,446,810 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-08 | 2022-09-09 | 237,619 | $42.74 | $10.16M | 8,577,140 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-09-07 | 2022-09-09 | 261,881 | $42.66 | $11.17M | 8,814,759 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2022-08-25 | 2022-08-29 | 500 | $44.00 | $22.0K | 9,076,640 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 2,292,617 | — | $0 | 178,821 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 907,714 | — | $0 | 70,800 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 347,752 | — | $0 | 2,032 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2020-06-18 | 2020-06-22 | 2,339,999 | — | $0 | 182,438 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 3,477,520 | — | $0 | 3,477,520 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 23,390,000 | — | $0 | 23,390,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 22,926,170 | — | $0 | 22,926,170 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-22 | 50,000 | $28.00 | $1.40M | 50,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2020-06-18 | 2020-06-22 | 9,077,140 | — | $0 | 9,077,140 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 978,514 | — | $0 | 978,514 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-22 | 349,784 | — | $0 | 349,784 | SEC↗ |